会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • KINASE INHIBITORS
    • 激酶INHIBITOREN
    • EP2493313A4
    • 2013-05-15
    • EP10827573
    • 2010-10-29
    • GENOSCOOSCOTEC INC
    • KIM HONG WOOKOH JONG SUNGLEE JAEKYOOSONG HO-JUHNKIM YOUNGSAMLEE HEE KYUCHOI JANG-SIKLIM SUN-HEECHANG SUNHWA
    • A61K31/519A61P25/28A61P29/00A61P35/00C07D471/04
    • A61K31/519C07D471/04
    • The present invention provides a new group of protein kinase inhibitors, pyrido[4,3,-d]pyrimidin-5-one derivatives, and pharmaceutically acceptable salts thereof that are useful for intreating cell proliferative disease and disorder such as cancer, autoimmune diseases, infection, cardiovascular disease and neurodegenerative disease and disorder. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefor. The invention also provides useful intermediates generated during the syntheses of the pyrido[4,3,-d]pyrimidin-5-one derivatives.
    • 本发明提供了一组新的蛋白激酶抑制剂,吡啶并[4,3,-d]嘧啶-5-酮衍生物及其药学上可接受的盐,其可用于促进细胞增殖性疾病和病症如癌症,自身免疫性疾病, 感染,心血管疾病和神经变性疾病和障碍。 本发明提供了合成和施用蛋白激酶抑制剂化合物的方法。 本发明还提供了包含至少一种蛋白激酶抑制剂化合物以及药学上可接受的载体,稀释剂或赋形剂的药物制剂。 本发明还提供了在吡啶并[4,3, - d]嘧啶-5-酮衍生物的合成过程中产生的有用的中间体。